Indo Us Biotech Limited has disclosed the resignation of Nehaben Sachinbhai Patel, who served as a Non-Executive Independent Director on the board. Patel tendered her resignation on 21 April 2026, and the board accepted it at its meeting held the same day. The communications indicate that her departure was prompted by personal and unavoidable reasons, with a request to be relieved from the post with immediate effect. Patel expresses gratitude for the opportunity to contribute to the company during her tenure.
In the filing, the company’s Managing Director, Jagdish Ajudiya, signs the notice on behalf of Indo Us Biotech Limited, underscoring that the board has formally recorded Patel’s exit. The move removes an independent voice from the governance mix, a development observers may watch closely as the company continues to steer its strategic agenda.
Patel’s resignation letter notes there are no other material reasons beyond those stated, leaving the duration and shape of the board’s independent oversight to the company’s forthcoming governance refresh. While the firm has not publicly outlined a replacement timeline, such vacancies typically prompt a search for suitable candidates to maintain balance on the board’s independent oversight.
As Indo Us Biotech navigates its growth trajectory, the departure of an independent director will likely prompt a period of board assessment and potential recruitment to ensure continuity of governance and independent counsel at the table.